XML 35 R24.htm IDEA: XBRL DOCUMENT

LONG-TERM INCENTIVE PLAN AWARDS (Tables)

3 Months Ended

Sep. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of stock options

Weighted-

Average

Weighted-

Remaining

Average

Contractual

Aggregate

Exercise

Life

Intrinsic

Options

Shares

Price

(In Years)

Value

Outstanding as of June 30, 2024

627,001

$

4.24

2.88

$

130,200

Granted

–

–

–

–

Exercised

–

–

–

–

Cancelled

–

–

–

–

Forfeited or expired

(7,000)

3.96

–

–

Outstanding as of September 30, 2024

620,001

$

4.22

1.63

$

434,400

Exercisable as of September 30, 2024

590,605

$

4.26

1.60

$

399,125

The aggregate intrinsic value in the preceding table represents the total pretax intrinsic value, based upon the Company’s closing stock price of $4.58 as of September 30, 2024, which would have been received by the option holders had all option holders exercised their options as of that date. The weighted-average grant-date fair value of stock options outstanding as of September 30, 2024, in the amount of 620,001 shares was $3.33 per share. As of September 30, 2024, there was unrecognized compensation cost of $83,199 related to non-vested stock options granted.

A summary of the status of our stock options is presented below as of September 30, 2023:

Weighted-

Average

Weighted-

Remaining

Average

Contractual

Aggregate

Exercise

Life

Intrinsic

Options

Shares

Price

(In Years)

Value

Outstanding as of June 30, 2023

647,001

$

4.24

2.88

$

130,200

Granted

–

–

–

–

Exercised

–

–

–

–

Cancelled

–

–

–

–

Forfeited or expired

(16,000)

4.77

–

–

Outstanding as of September 30, 2023

631,001

$

4.23

2.63

$

–

Exercisable as of September 30, 2023

478,642

$

4.49

2.44

$

–